Spoken Alpha · Executive

Charles Evan Ballantyne

Chief Financial OfficerGANXGain Therapeutics, Inc.

In our data from Apr 10, 2023

No earnings-call appearances indexed yet.

Role timeline

GANXGain Therapeutics, Inc.
Chief Financial Officer
Apr 10, 2023 – Apr 10, 2023 · source: edgar_form4
AGENAGENUS INC
CFO
Jun 14, 2016 – Jun 14, 2016 · source: edgar_form4
AGENAGENUS INC
Chief Financial Officer
Jun 17, 2015 – Apr 26, 2016 · source: edgar_form4
TOVXTheriva Biologics, Inc.
Chief Financial Officer
Jan 8, 2015 – Jan 8, 2015 · source: edgar_form4

Research tier

See how this executive's language deviates from their own baseline

Sign in to view the per-call Behavioral Lean, the language-deviation timeline, and the novel forward-guidance phrases flagged across this executive's earnings calls — each scored against their own prior-call history.

Sign in to view Request research access

Call appearances in our data

No earnings-call appearances indexed for this executive yet.